{
    "2020-09-27": [
        [
            {
                "time": "",
                "original_text": "医药行业一周观察：海外第二波疫情来袭 关注检测板块业绩弹性",
                "features": {
                    "keywords": [
                        "医药行业",
                        "海外",
                        "第二波疫情",
                        "检测板块",
                        "业绩弹性"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业周报：持续布局高景气板块 开始关注三季报预期",
                "features": {
                    "keywords": [
                        "医药行业",
                        "高景气板块",
                        "三季报预期"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物业33只股上榜百元股，四家药企收盘价超300元",
                "features": {
                    "keywords": [
                        "医药生物",
                        "百元股",
                        "药企",
                        "收盘价",
                        "300元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗健康：国内免疫治疗创新靶点不断涌现 复杂制剂是未来创新方向之一",
                "features": {
                    "keywords": [
                        "医疗健康",
                        "免疫治疗",
                        "创新靶点",
                        "复杂制剂",
                        "未来创新方向"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}